Salisu A Aikoye, MD
Psychiatry · Norwalk
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 21 years
- Graduated 2005
Offices
2 locations · Sal Psychiatry Services PC · 2 clinicians in this group
Hospitals listed: College Medical Center · Pacifica Hospital of the Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aikoye’s office at (562) 280-7176 to ask if they take your plan before you enroll.
California Medical Board record
Licence A154761 · Current
Licensed to practise in California · since 2018 · expires 2027-08-31 · University of Ibadan College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Addiction Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- College Medical CenterLong Beach, CAAcute Care Hospital · Proprietary · Has an emergency department57% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- Pacifica Hospital of the ValleySun Valley, CAAcute Care Hospital · Proprietary · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for College Medical Center
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 5 the same, 0 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 185 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.47 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 384 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,485 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.52) · 1,504 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.39 (0.79 to 6) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.59 to 4.04) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 1.4) · 1,344 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.12 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.525 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 54 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -11.4 · 87 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.8) · 128 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 64% |
| Staff "always" explained | 46% |
| Yes, staff "did" give patients this information | 70% |
| Yes, staff "did" give patients information about help after discharge | 71% |
| Doctors "always" explained things so they could understand | 54% |
| Doctors "always" listened carefully | 60% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 57% |
| Nurses "always" explained things so they could understand | 63% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 36% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 35% |
| Yes, staff "did" give patients information about possible symptoms | 70% |
See every measure and the patient survey for Pacifica Hospital of the Valley
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.05 (0 to 2.15) · 40 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.47 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 82 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 710 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 710 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.7) · 572 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.291 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.212 | No different | Oct 2024 – Sep 2025 |
Original Medicare doctor bills
$53,466
Medicare paid this office $53,466 for 148 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 54 | $13,670 | $89 |
| Psychotherapy, 1 hour | 14 | $5,694 | $105 |
| Short return visit (20+ min) | 31 | $3,912 | $56 |
| Psychiatric diagnostic evaluation with medical services | 29 | $3,648 | $126 |
| Long return visit (40+ min) | 12 | $2,953 | $141 |
See all 9 services
| Return visit (30+ min) | 54 | $13,670 | $89 |
| Psychotherapy, 1 hour | 14 | $5,694 | $105 |
| Short return visit (20+ min) | 31 | $3,912 | $56 |
| Psychiatric diagnostic evaluation with medical services | 29 | $3,648 | $126 |
| Long return visit (40+ min) | 12 | $2,953 | $141 |
| Psychotherapy with evaluation and management visit, 30 minutes | 23 | $2,324 | $55 |
| Psychiatric diagnostic evaluation | 14 | $1,862 | $133 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,402 | $67 |
| Psychotherapy, 30 minutes | 11 | $1,169 | $56 |
Who their Medicare patients are
148 Original Medicare patients in 2024. Average age 66 · Under 65 35% · 85 and older 10% · Women 60% · Also on Medicaid 80% · Health risk score 2.12. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 75% · Depression 72% · Diabetes 46% · Dementia 38% · Heart failure 32% · Chronic kidney disease 31% · COPD 29% · Coronary heart disease 25% · Stroke 14% · Cancer 11% · Atrial fibrillation 10%.
The office billed $183,296, Medicare allowed $72,164 and paid $53,466; for 542 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 148 | 542 | 66 | 2.12 | $183,296 | $53,466 |
| 2023 | 266 | 1,098 | 65 | 2.57 | $309,057 | $107,018 |
| 2022 | 121 | 627 | 67 | 2.47 | $152,664 | $64,830 |
| 2021 | 56 | 195 | 61 | 2.21 | $43,760 | $21,346 |
| 2020 | 22 | 43 | 61 | 1.56 | $11,275 | $4,003 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 121 | $31,883 | $82 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 50 | $20,309 | $127 |
| Psychiatric diagnostic evaluation with medical services | 108 | $14,234 | $127 |
| Psychiatric diagnostic evaluation with medical services | 43 | $6,402 | $142 |
| Psychotherapy, 1 hour | 13 | $4,322 | $111 |
| Psychiatric diagnostic evaluation | 34 | $4,166 | $123 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 18 | $3,932 | $116 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 33 | $3,793 | $64 |
| Long return visit (40+ min) | 18 | $2,951 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,121 | $66 |
| Psychiatric diagnostic evaluation | 15 | $1,869 | $125 |
| Short return visit (20+ min) | 24 | $1,447 | $60 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,226 | $47 |
| Residence visit for established patient with straightforward medical decision making, per day at least 15 minutes | 15 | $604 | $38 |
2022: 8 services
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 35 | $15,764 | $114 |
| Long return visit (40+ min) | 19 | $15,130 | $154 |
| Psychotherapy with evaluation and management visit, 30 minutes | 33 | $10,078 | $59 |
| Return visit (30+ min) | 24 | $8,843 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,343 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,987 | $86 |
| Psychiatric diagnostic evaluation with medical services | 13 | $1,916 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $962 | $60 |
2021: 5 services
| Long return visit (40+ min) | 11 | $4,954 | $160 |
| Psychotherapy with evaluation and management visit, 30 minutes | 21 | $4,027 | $61 |
| New patient visit (60+ min) | 13 | $2,371 | $182 |
| Return visit (30+ min) | 14 | $2,361 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,885 | $171 |
Medicaid work
$26,349 in 2024
Medicaid paid $26,349 for 708 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychotherapy, 60 minutes with patient | 188 | $10,322 |
| Return visit (30+ min) | 245 | $10,022 |
| PSYCH DIAGNOSTIC EVALUATION | 37 | $2,371 |
| Short return visit (20+ min) | 176 | $2,194 |
| PSYCHOTHERAPY W/PATIENT 30 MINUTES | 49 | $1,142 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 13 | $298 |
| 2024 | 708 | 6 | 28 | $26,349 |
| 2023 | 1,143 | 6 | 84 | $11,449 |
| 2022 | 53 | 2 | 25 | $1,252 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 696 | $5,510 |
| Psychotherapy, 60 minutes with patient | 278 | $3,292 |
| Psychiatric diagnostic evaluation with medical services | 107 | $2,023 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 28 | $272 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 15 | $224 |
| PSYCH DIAGNOSTIC EVALUATION | 19 | $129 |
2022
| Return visit (30+ min) | 23 | $934 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 30 | $318 |
Drugs they prescribed that Part D paid
$352,109
Pharmacies billed $352,109 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,878) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
2,749 generic and 129 brand-name prescriptions · $352,109 in drug cost · 426 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Abilify Maintena | 28 | $77,758 | $2,777 |
| Invega Sustenna | 13 | $30,274 | $2,329 |
| Latuda | 13 | $27,648 | $2,127 |
| Lurasidone | 55 | $26,138 | $475 |
| Rexulti | 16 | $24,303 | $1,519 |
See all 46 drugs
| Abilify Maintena | 28 | $77,758 | $2,777 |
| Invega Sustenna | 13 | $30,274 | $2,329 |
| Latuda | 13 | $27,648 | $2,127 |
| Lurasidone | 55 | $26,138 | $475 |
| Rexulti | 16 | $24,303 | $1,519 |
| Aripiprazole | 217 | $15,327 | $71 |
| Buprenorphine-Naloxone | 43 | $6,011 | $140 |
| Paliperidone Er | 12 | $5,049 | $421 |
| Quetiapine | 218 | $4,877 | $22 |
| Quetiapine Fumarate Er | 66 | $3,590 | $54 |
| Haloperidol | 56 | $2,283 | $41 |
| Divalproex Sodium Er | 54 | $2,237 | $41 |
| Ziprasidone | 37 | $1,914 | $52 |
| Olanzapine | 71 | $1,489 | $21 |
| Varenicline | 12 | $1,335 | $111 |
| Gabapentin | 105 | $1,078 | $10 |
| Venlafaxine Hcl Er | 77 | $1,055 | $14 |
| Mirtazapine | 175 | $1,006 | $6 |
| Hydroxyzine Pamoate | 103 | $961 | $9 |
| Duloxetine | 63 | $900 | $14 |
| Risperidone | 100 | $837 | $8 |
| Benztropine Mesylate | 96 | $816 | $9 |
| Escitalopram | 133 | $761 | $6 |
| Trazodone | 170 | $710 | $4 |
| Sertraline | 127 | $609 | $5 |
| Divalproex | 30 | $599 | $20 |
| Naltrexone | 20 | $576 | $29 |
| Lithium Carbonate Er | 63 | $541 | $9 |
| Lamotrigine | 70 | $506 | $7 |
| Buspirone | 64 | $468 | $7 |
| Doxepin | 21 | $400 | $19 |
| Fluoxetine | 70 | $378 | $5 |
| Paroxetine | 57 | $376 | $7 |
| Perphenazine | 20 | $327 | $16 |
| Hydroxyzine | 22 | $301 | $14 |
| Lithium Carbonate | 22 | $292 | $13 |
| Prazosin | 19 | $255 | $13 |
| Topiramate | 43 | $254 | $6 |
| Clonazepam | 22 | $254 | $12 |
| Bupropion Xl | 29 | $235 | $8 |
| Amitriptyline | 16 | $177 | $11 |
| Bupropion Hcl Sr | 12 | $119 | $10 |
| Propranolol | 13 | $97 | $7 |
| Citalopram Hbr | 22 | $43 | $2 |
| Temazepam | 11 | $31 | $3 |
| Alprazolam | 24 | $15 | $1 |
Year by year
| 2024 | 2,878 | 257 | 0% (0) | 4% | $352,109 |
| 2023 | 2,948 | 215 | 0% (0) | 4% | $454,443 |
| 2022 | 2,093 | 128 | 0% (0) | 6% | $378,407 |
| 2021 | 1,379 | 97 | 0% (0) | None | $332,764 |
| 2020 | 278 | 43 | 0% (0) | 5% | $36,951 |
| 2016 | 41 | None | 0% (0) | None | $3,379 |
| 2015 | 16 | None | 0% (0) | None | $530 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Invega Sustenna | 38 | $118,711 | $3,124 |
| Abilify Maintena | 38 | $109,089 | $2,871 |
| Latuda | 15 | $29,942 | $1,996 |
| Aripiprazole | 234 | $28,148 | $120 |
| Lurasidone | 32 | $17,990 | $562 |
| Quetiapine Fumarate Er | 81 | $17,433 | $215 |
| Quetiapine | 273 | $11,027 | $40 |
| Olanzapine | 83 | $5,648 | $68 |
| Divalproex Sodium Er | 57 | $4,880 | $86 |
| Ziprasidone | 20 | $3,236 | $162 |
| Duloxetine | 84 | $3,151 | $38 |
| Haloperidol | 69 | $2,759 | $40 |
| Trazodone | 193 | $2,524 | $13 |
| Mirtazapine | 197 | $2,380 | $12 |
| Venlafaxine Hcl Er | 76 | $2,321 | $31 |
| Sertraline | 154 | $2,057 | $13 |
| Buspirone | 75 | $2,025 | $27 |
| Benztropine Mesylate | 116 | $1,807 | $16 |
| Risperidone | 85 | $1,682 | $20 |
| Escitalopram | 132 | $1,607 | $12 |
| Temazepam | 29 | $1,588 | $55 |
| Naltrexone | 25 | $1,585 | $63 |
| Hydroxyzine Pamoate | 101 | $1,572 | $16 |
| Divalproex | 36 | $1,478 | $41 |
| Prazosin | 29 | $1,409 | $49 |
| Oxcarbazepine | 12 | $1,303 | $109 |
| Gabapentin | 80 | $1,163 | $15 |
| Lamotrigine | 59 | $1,055 | $18 |
| Topiramate | 59 | $962 | $16 |
| Fluoxetine | 62 | $896 | $14 |
| Paroxetine | 55 | $690 | $13 |
| Perphenazine | 12 | $614 | $51 |
| Amitriptyline | 19 | $500 | $26 |
| Lithium Carbonate Er | 39 | $421 | $11 |
| Citalopram Hbr | 25 | $408 | $16 |
| Bupropion Xl | 23 | $385 | $17 |
| Doxepin | 11 | $370 | $34 |
| Loxapine | 12 | $338 | $28 |
| Lithium Carbonate | 18 | $164 | $9 |
| Hydroxyzine | 12 | $121 | $10 |
| Clonidine | 13 | $110 | $8 |
| Zaleplon | 12 | $69 | $6 |
| Alprazolam | 27 | $66 | $2 |
2022: 42 drugs
| Abilify Maintena | 32 | $86,246 | $2,695 |
| Latuda | 37 | $66,655 | $1,801 |
| Invega Sustenna | 21 | $61,191 | $2,914 |
| Aripiprazole | 143 | $44,374 | $310 |
| Quetiapine | 139 | $9,473 | $68 |
| Duloxetine | 78 | $7,397 | $95 |
| Quetiapine Fumarate Er | 55 | $7,348 | $134 |
| Paliperidone Er | 14 | $5,941 | $424 |
| Haloperidol | 52 | $2,067 | $40 |
| Mirtazapine | 172 | $1,799 | $10 |
| Prazosin | 28 | $1,732 | $62 |
| Sertraline | 167 | $1,398 | $8 |
| Divalproex Sodium Er | 23 | $1,364 | $59 |
| Buspirone | 58 | $1,213 | $21 |
| Gabapentin | 85 | $1,137 | $13 |
| Fluoxetine | 45 | $1,121 | $25 |
| Hydroxyzine Pamoate | 92 | $1,048 | $11 |
| Benztropine Mesylate | 62 | $978 | $16 |
| Venlafaxine Hcl Er | 55 | $931 | $17 |
| Trazodone | 107 | $919 | $9 |
| Doxepin | 15 | $825 | $55 |
| Risperidone | 41 | $719 | $18 |
| Escitalopram | 89 | $703 | $8 |
| Oxcarbazepine | 14 | $652 | $47 |
| Divalproex | 37 | $638 | $17 |
| Topiramate | 44 | $626 | $14 |
| Olanzapine | 45 | $592 | $13 |
| Perphenazine | 12 | $508 | $42 |
| Amitriptyline | 18 | $459 | $26 |
| Paroxetine | 53 | $342 | $6 |
| Loxapine | 12 | $324 | $27 |
| Lamotrigine | 22 | $289 | $13 |
| Venlafaxine | 13 | $277 | $21 |
| Lithium Carbonate Er | 12 | $249 | $21 |
| Zaleplon | 13 | $175 | $13 |
| Lithium Carbonate | 19 | $172 | $9 |
| Bupropion Xl | 14 | $142 | $10 |
| Temazepam | 21 | $140 | $7 |
| Hydroxyzine | 11 | $70 | $6 |
| Citalopram Hbr | 15 | $49 | $3 |
| Clonazepam | 13 | $42 | $3 |
| Alprazolam | 25 | $32 | $1 |
2021: 32 drugs
| Abilify Maintena | 44 | $112,021 | $2,546 |
| Invega Sustenna | 27 | $74,024 | $2,742 |
| Latuda | 26 | $36,758 | $1,414 |
| Aripiprazole | 103 | $16,176 | $157 |
| Paliperidone Er | 15 | $4,868 | $325 |
| Quetiapine | 122 | $3,554 | $29 |
| Haloperidol | 33 | $1,480 | $45 |
| Venlafaxine Hcl Er | 37 | $1,261 | $34 |
| Duloxetine | 37 | $1,197 | $32 |
| Trazodone | 97 | $953 | $10 |
| Olanzapine | 36 | $922 | $26 |
| Prazosin | 17 | $891 | $52 |
| Divalproex Sodium Er | 15 | $817 | $54 |
| Quetiapine Fumarate Er | 23 | $801 | $35 |
| Gabapentin | 47 | $793 | $17 |
| Benztropine Mesylate | 46 | $771 | $17 |
| Sertraline | 113 | $675 | $6 |
| Buspirone | 32 | $602 | $19 |
| Risperidone | 40 | $561 | $14 |
| Mirtazapine | 65 | $547 | $8 |
| Escitalopram | 46 | $478 | $10 |
| Hydroxyzine Pamoate | 49 | $439 | $9 |
| Topiramate | 33 | $435 | $13 |
| Lamotrigine | 15 | $400 | $27 |
| Paroxetine | 25 | $326 | $13 |
| Amitriptyline | 12 | $247 | $21 |
| Fluoxetine | 28 | $229 | $8 |
| Lithium Carbonate | 13 | $162 | $12 |
| Divalproex | 11 | $140 | $13 |
| Temazepam | 11 | $128 | $12 |
| Hydroxyzine | 11 | $73 | $7 |
| Citalopram Hbr | 15 | $72 | $5 |
2020: 9 drugs
| Aripiprazole | 24 | $4,037 | $168 |
| Olanzapine | 18 | $471 | $26 |
| Trazodone | 24 | $308 | $13 |
| Quetiapine | 21 | $301 | $14 |
| Benztropine Mesylate | 11 | $156 | $14 |
| Risperidone | 12 | $156 | $13 |
| Sertraline | 15 | $140 | $9 |
| Fluoxetine | 13 | $116 | $9 |
| Escitalopram | 11 | $95 | $9 |
Money from drug and device companies
$225 in 2025
| 2025 | 2 | 2 | None | $225 |
| 2024 | 3 | 5 | None | $135 |
| 2023 | 1 | 2 | None | $36 |
| 2022 | 4 | 20 | None | $382 |
| 2021 | 2 | 3 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Otsuka America Pharmaceutical | Abilify Maintena | $120 | 1 payment
|
| Axsome Therapeutics | Auvelity | $104 | 1 payment
|
See all 2 published payments
| Axsome Therapeutics | Meals · 2025-12-01 | Auvelity | $104 |
| Otsuka America Pharmaceutical | Meals · 2025-06-23 | Abilify Maintena | $120 |
See earlier years (2024, 2023, 2022, 2021)
2024: $135
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $80 | 3 payments
|
| Indivior | Sublocade | $28 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $27 | 1 payment
|
2023: $36
| Janssen Pharmaceuticals | Spravato | $36 | 2 payments
|
2022: $382
| Janssen Pharmaceuticals | Invega Sustenna | $154 | 7 payments
|
| Iti | Caplyta | $145 | 10 payments
|
| Teva Pharmaceuticals USA | Austedo | $41 | 1 payment
|
| Otsuka America Pharmaceutical | Abilify Maintena | $41 | 2 payments
|
2021: $93
| Iti | Caplyta | $47 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $46 | 2 payments
|
Professional record
- NPI
- 1497173694
- Licence
- CA A154761, MI 4301107569California A154761: Current · expires 2027-08-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084P0802X (2084P0802X)
- Mailing address
- 13132 Studebaker Rd Ste 10, Norwalk, CA, 90650
- NPI first listed
- 2014-04-03
- NPI last updated
- 2024-03-26
- NPI record certified
- 2024-03-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 12440 Firestone Blvd Ste 310, Norwalk, CA, 90650